[go: up one dir, main page]

MX2009010252A - Combinacion simbiotica para mejorar la microbiota intestinal. - Google Patents

Combinacion simbiotica para mejorar la microbiota intestinal.

Info

Publication number
MX2009010252A
MX2009010252A MX2009010252A MX2009010252A MX2009010252A MX 2009010252 A MX2009010252 A MX 2009010252A MX 2009010252 A MX2009010252 A MX 2009010252A MX 2009010252 A MX2009010252 A MX 2009010252A MX 2009010252 A MX2009010252 A MX 2009010252A
Authority
MX
Mexico
Prior art keywords
3galî2l
galî2l
4glc
galî2
6galî2l
Prior art date
Application number
MX2009010252A
Other languages
English (en)
Other versions
MX337667B (es
Inventor
Norbert Sprenger
Marie-Claire Fichot
Karl-Josef Huber-Haag
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2009010252A publication Critical patent/MX2009010252A/es
Publication of MX337667B publication Critical patent/MX337667B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe el uso de una cepa probiótica de Lactobacillus rhamnosus y una mezcla oligsacárida la cual comprende 5-70% en peso de por lo menos un oligosacárido N-acetilado que se selecciona del grupo que comprende GalNAca1,3Galß1,4Glc y Galß1,6GalNAcal,3Galß1,4Glc, 20-90% en peso de por lo menos un oligosacárido neutro que se selecciona del grupo que comprende Galß1,6Gal, Galß1,6Galß1,4Glc Galß1,6Galß1,6G1c, Galß1, 3Galß1, 3Glc, Galß1, 3Galß1, 4Glc, Galß1,6Galß1,6Galß1,4Glc, Galß1,6Galß1,3Galß1,4Glc, Galß1,3Galß1,6Galß14Glc y Galß1,3Galß1,3Galß1,4Glc y 5-50% en peso de por lo menos un oligosacárido sialilado que se selecciona del grupo que comprende NeuAca2,3Galß1,4Glc y NeuAca2,6Galß1,4Glc en la elaboración de un medicamento o una composición nutricional terapéutica para promover el desarrollo de una microbiota intestinal bifidogénica temprana en lactantes quienes han nacido por cesárea.
MX2009010252A 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal. MX337667B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053661 WO2008116916A1 (en) 2007-03-28 2008-03-27 Synbiotic to improve gut microbiota

Publications (2)

Publication Number Publication Date
MX2009010252A true MX2009010252A (es) 2009-10-13
MX337667B MX337667B (es) 2016-03-14

Family

ID=38051788

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.

Country Status (15)

Country Link
US (4) US20100119488A1 (es)
EP (6) EP1974743A1 (es)
CN (4) CN101652080A (es)
AU (4) AU2008231775A1 (es)
BR (4) BRPI0809356A2 (es)
CA (4) CA2678994A1 (es)
ES (2) ES2434566T3 (es)
MX (4) MX2009009931A (es)
MY (1) MY151137A (es)
PL (2) PL2131680T3 (es)
PT (2) PT2131680E (es)
RU (4) RU2009139667A (es)
UA (2) UA97662C2 (es)
WO (4) WO2008116892A1 (es)
ZA (3) ZA200907538B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
ES2553636T3 (es) 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
US20090214594A1 (en) * 2006-06-13 2009-08-27 Nestec S.A. Prevention and Treatment of Otitis Media with Non-Pathogenic Bacterial Strains
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
EP2373182A1 (en) * 2008-12-05 2011-10-12 Nestec S.A. Compositions for use in low-birth weight infants
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
US20120121562A1 (en) * 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
TR201807143T4 (tr) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
MX2013007737A (es) * 2010-12-29 2013-07-24 Nestec Sa Fibra y probioticos para reducir sintomas intestinales relacionados con estres.
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
DK3366143T3 (da) 2011-06-20 2025-01-27 Heinz Co Brands H J Llc Probiotiske sammensætninger og fremgangsmåder
US9463169B2 (en) 2011-08-17 2016-10-11 Microbiome Therapeutics, Llc Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation
US9781947B2 (en) * 2011-10-18 2017-10-10 Nestec S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
CN104160014A (zh) 2011-12-01 2014-11-19 国立大学法人东京大学 诱导调节性t细胞的增殖或积累的人源细菌
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
MX370692B (es) 2013-05-10 2019-12-19 Heinz Co Brands H J Llc Probióticos y métodos de uso.
US10758555B2 (en) 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
MX2016006220A (es) * 2013-11-15 2016-08-08 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea.
WO2015071403A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
WO2015071402A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
RU2699981C2 (ru) 2014-08-18 2019-09-11 Сосьете Де Продюи Нестле С.А. Пребиотики для снижения риска развития ожирения в дальнейшей жизни
KR20170072879A (ko) * 2014-10-29 2017-06-27 네스텍 소시에테아노님 생애 초기에 미생물총 불균형을 회복하기 위한 l. 루테리의 용도
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
AU2016303003A1 (en) * 2015-08-04 2017-12-07 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN108495562A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 具有特异性低聚糖的用于预防或治疗变态反应的组合物
TWI784953B (zh) * 2016-05-31 2022-12-01 日商森永乳業股份有限公司 短雙岐桿菌及/或含有其培養物之用途
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
AU2017307952A1 (en) * 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
MX2019013143A (es) * 2017-05-05 2020-07-14 Nestle Sa Tratamiento de colicos infantiles.
AU2018310705B2 (en) * 2017-08-04 2024-01-18 Societe Des Produits Nestle S.A. Probiotic bacteria preconditioned in a GOS-containing medium and use thereof
US20220010267A1 (en) * 2018-05-30 2022-01-13 Evolve Biosystems, Inc. Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
WO2020251249A1 (ko) * 2019-06-11 2020-12-17 주식회사 천랩 영유아의 장내 미생물 불균형도를 탐지하는 방법
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
JP2025521180A (ja) * 2022-06-10 2025-07-08 ディーエスエム アイピー アセッツ ビー．ブイ． ビタミンＢ２及びラクトバチルス・ラムノサス（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｒｈａｍｎｏｓｕｓ）を含む組み合わせ
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
CN120390793A (zh) 2022-11-17 2025-07-29 法国国家农业食品与环境研究院 黏膜乳杆菌和需要glp-1增加的疾病
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
ES2102485T3 (es) * 1992-07-06 1997-08-01 Nestle Sa Bacteria lactica.
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
US20060275895A1 (en) 2003-06-27 2006-12-07 Bio-Circuit Biogas producing facility with anaerobic hydrolysis
RU2428886C2 (ru) * 2005-04-13 2011-09-20 Нестек С.А. Смесь для грудных детей, содержащая пробиотики
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US8361530B2 (en) * 2006-02-10 2013-01-29 Nestec S.A. Oligosaccharide mixture
ES2553636T3 (es) * 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
US20090214594A1 (en) * 2006-06-13 2009-08-27 Nestec S.A. Prevention and Treatment of Otitis Media with Non-Pathogenic Bacterial Strains

Also Published As

Publication number Publication date
AU2008231702B2 (en) 2014-01-16
WO2008116904A1 (en) 2008-10-02
BRPI0809355A2 (pt) 2014-09-02
BRPI0809626A2 (pt) 2014-09-23
US20100150874A1 (en) 2010-06-17
US20100086527A1 (en) 2010-04-08
EP2131859A1 (en) 2009-12-16
AU2008231763B2 (en) 2013-10-31
AU2008231778A1 (en) 2008-10-02
CN101652079A (zh) 2010-02-17
EP2489280A2 (en) 2012-08-22
EP2489280A3 (en) 2013-06-26
EP2129242A1 (en) 2009-12-09
PT2131680E (pt) 2013-10-28
ES2434566T3 (es) 2013-12-16
RU2456008C2 (ru) 2012-07-20
MX2009009931A (es) 2009-09-24
RU2009139660A (ru) 2011-05-10
US20100119488A1 (en) 2010-05-13
WO2008116907A1 (en) 2008-10-02
ZA200907538B (en) 2011-04-28
RU2009139667A (ru) 2011-05-10
CA2682654A1 (en) 2008-10-02
CN101646452A (zh) 2010-02-10
PL2131859T3 (pl) 2016-12-30
EP1974743A1 (en) 2008-10-01
PL2131680T3 (pl) 2014-01-31
MX2009009442A (es) 2009-09-14
BRPI0809356A2 (pt) 2014-09-02
AU2008231763A1 (en) 2008-10-02
CN101652080A (zh) 2010-02-17
ZA200907731B (en) 2011-04-28
ZA200907541B (en) 2011-04-28
MX337667B (es) 2016-03-14
AU2008231775A1 (en) 2008-10-02
BRPI0809622A2 (pt) 2014-09-16
CA2679081A1 (en) 2008-10-02
CA2680093A1 (en) 2008-10-02
EP2131680B1 (en) 2013-08-14
UA97662C2 (ru) 2012-03-12
CA2678994A1 (en) 2008-03-27
EP2131859B1 (en) 2016-04-27
UA97663C2 (ru) 2012-03-12
WO2008116916A1 (en) 2008-10-02
WO2008116892A1 (en) 2008-10-02
RU2009139669A (ru) 2011-05-10
EP2129393A1 (en) 2009-12-09
RU2521500C2 (ru) 2014-06-27
US20100119497A1 (en) 2010-05-13
EP2131680A1 (en) 2009-12-16
MY151137A (en) 2014-04-30
AU2008231702A1 (en) 2008-10-02
CN101646453A (zh) 2010-02-10
RU2009139658A (ru) 2011-05-10
ES2577434T3 (es) 2016-07-14
MX2009009318A (es) 2009-09-10
PT2131859T (pt) 2016-07-13

Similar Documents

Publication Publication Date Title
MX337667B (es) Combinacion simbiotica para mejorar la microbiota intestinal.
RU2008139598A (ru) Синбиотическая смесь
Gibson Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin
Chow Probiotics and prebiotics: a brief overview
RU2010153257A (ru) Пробиотики для улудшения микробиоты пищеварительного тракта
Vernazza et al. Human colonic microbiology and the role of dietary intervention: introduction to prebiotics
AU2019400658B2 (en) A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
EP2643004B1 (en) Oligosaccharide composition for treating skin diseases
RU2014119844A (ru) Композиция для головного мозга и/или познавательного и/или психомоторного развития
Singh et al. Gut microbiome as a novel cardiovascular therapeutic target
RU2010142003A (ru) Синбиотическая смесь
RU2011104195A (ru) Питательная композиция, содержащая смесь олигосахаридов
RU2014119930A (ru) Композиция, предназначенная для применения в стимулировании здорового костного роста и/или в профилактике, и/или терапии заболеваний кости
UA102830C2 (ru) Профилактика условно-патогенных инфекций у лиц со сниженным иммунитетом
MY146109A (en) Oligosaccharide mixture
CN105283195A (zh) 用于治疗过敏患者的感染的合生素组合物
RU2011106319A (ru) Пробиотики для увелечения секреции iga у младенцев, рожденных посредством кесарева сечения
RU2014119904A (ru) Композиция для применения при стимуляции ангиогенеза в кишечнике, всасывания питательных веществ и переносимости энтерального питания, и/или при профилактике, и/или лечении воспалительных заболеваний кишечника, и/или при выздоровлении после повреждения кишечника и хирургического вмешательства
RU2012117804A (ru) Bifidobacterium longum atcc baa-999 (bl999) и контролирование веса
Ogueke et al. Probiotics and prebiotics: Unfolding prospects for better human health
NZ602249A (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
RU2010126327A (ru) Композиция на основе пробиотических бактерий совместно с пребиотиком и ее применение в предупреждении и/или лечении респираторных патологий и/или инфекций и для улучшения функций кишечника
RU2016129426A (ru) Питательная композиция для снижения метаболического стресса у младенцев
PT2241196E (pt) Suplemento nutricional compreendendo oligossacarídeos e cisteína para o tratamento do vih
AU2019407214B2 (en) A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration